Sino Medical Sciences Technology In (688108) — Net Asset Quality Index
Sino Medical Sciences Technology In (688108) has a Net Asset Quality Index of 69.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.34 Billion minus total liabilities of CN¥407.00 Million yields net assets of CN¥931.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Sino Medical Sciences Technology In (688108) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sino Medical Sciences Technology In Net Asset Quality Index Over Time (2016–2024)
This chart shows how Sino Medical Sciences Technology In's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 69.6%, representing net assets of CN¥931.81 Million against total assets of CN¥1.34 Billion CNY. See 688108 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Sino Medical Sciences Technology In (2016–2024)
The table below presents the year-by-year Net Asset Quality Index for Sino Medical Sciences Technology In from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Sino Medical Sciences Technology In market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.1% | CN¥898.34 Million | CN¥1.30 Billion | CN¥402.22 Million | ▼ -3.6 pp |
| 2023 | 72.7% | CN¥861.65 Million | CN¥1.19 Billion | CN¥324.17 Million | ▼ -10.5 pp |
| 2022 | 83.1% | CN¥887.48 Million | CN¥1.07 Billion | CN¥180.13 Million | ▼ -2.6 pp |
| 2021 | 85.7% | CN¥945.16 Million | CN¥1.10 Billion | CN¥157.92 Million | ▼ -2.8 pp |
| 2020 | 88.5% | CN¥1.08 Billion | CN¥1.22 Billion | CN¥139.63 Million | ▼ -2.6 pp |
| 2019 | 91.1% | CN¥1.10 Billion | CN¥1.21 Billion | CN¥107.11 Million | ▲ +4.1 pp |
| 2018 | 87.0% | CN¥701.28 Million | CN¥806.10 Million | CN¥104.83 Million | ▲ +1.6 pp |
| 2017 | 85.4% | CN¥606.70 Million | CN¥710.33 Million | CN¥103.62 Million | ▲ +13.2 pp |
| 2016 | 72.2% | CN¥202.75 Million | CN¥280.81 Million | CN¥78.06 Million | — |